semaglutide side effects joint pain Patel it Like it is: The long-term of taking Semaglutide May Reverse Damage Caused

In the SURMOUNT-1 trial for tirzepatide (Mounjaro), a hair loss incidence of up to 5% was documented among participants receiving the highest doses

Learn more : What is Semaglutide

How the Retatrutide Pen Will Likely Work When Approved No commercial pen specifications have been released

This triple action makes it more powerful in terms of both appetite control and fat burning

It is currently in Phase 3 clinical trials, and approval is not expected for at least another 1-2 years at the earliest

However, each medicine comes with its own pros and cons based on your medical history and the drugs you are already taking